BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 28
• 29
• 30

• Drug Development

  Speedel Pharmaceuticals, Inc. Release: Aliskiren, The First Effective Oral Renin Inhibitor, Provides Sustained 24 Hour Blood Pressure Control In Combination With Angiotensin Receptor Blocker

  November 16, 2005

   · 

  8 min read
• Drug Development

  NicOx SA Announces Results Of A Phase 2 Trial For NCX 4016 In PAOD

  November 16, 2005

   · 

  1 min read
• Drug Development

  Adherex Technologies Inc. Announces Global Development Plans For Advancing Eniluracil Into Phase III By Mid 2007

  November 16, 2005

   · 

  1 min read
• Drug Development

  ViRexx Medical Corp. Announces Postive Interim Results For Occlusin’TM’ 50 Injection

  November 16, 2005

   · 

  1 min read
• Business

  Wex Pharmaceuticals Inc. Reports Second Quarter Financial Results

  November 16, 2005

   · 

  1 min read
• Drug Development

  Extended Follow-up Of Renal Cancer Patients Provides New Support For Antisoma PLC’s AS1411

  November 16, 2005

   · 

  1 min read
• Drug Development

  Abbott Laboratories Heart Drug Levosimendan (Simdax) Fails To Prolong Life In Study

  November 16, 2005

   · 

  5 min read
• Deals

  Health Discovery Corporation Announces Sale Of Biomarker Signature For AIDS

  November 16, 2005

   · 

  1 min read
• Business

  Schering-Plough Corporation And OncoMethylome Sciences S.A. Announce License And Collaboration Agreement For Use Of OMS Pharmacogenomic Technology

  November 16, 2005

   · 

  8 min read
• Drug Development

  Tapestry Pharmaceuticals, Inc. Presents Data Characterizing Its Novel Third Generation Taxane, TPI 287, At AACR/NCI/EORTC Cancer Meeting

  November 16, 2005

   · 

  4 min read